Program Summary
A review of the literature indicates an increased incidence of gadolinium deposition in the brain as a result of repeated contrast-enhanced MR imaging procedures. With a wide selection of gadolinium-based contrast agents available; imaging professionals must be aware of their chemical make-up when selecting the best agent for a particular study.
In this first of a four-part CME/CE Accredited Expert Forum Webcast Series, Dr. Kenneth Maravilla reviews the safety profiles of the currently available agents, identifies the risk factors for NSF and discusses the current understanding and outstanding issues related to Gadolinium deposition in the brain and other tissues in patients with normal renal function.
Following Dr. Maravilla's presentation, a panel discussion was moderated by Dr. Lawrence Tanenbaum; where questions from the audience were addressed.
Effective Date: June 7, 2016
Expiration Date: June 30, 2018
Estimated Completion Time:1 hour
This program was originally broadcast live and supported through an unrestricted educational grant from Guerbet, LLC
This program has been supported through an unrestricted educational grant from Guerbet, LLC.
Faculty
Kenneth Maravilla, MD
Professor, Radiology & Neurological Surgery
Director, MR Research Laboratory
University of Washington
Lawrence N. Tanenbaum, MD, FACR
Vice President & Medical Director Eastern Region
Director of MRI, CT and Advanced Imaging
RadNet, Inc
Educational Objectives
After completing this course the participant should be able to:
- Recognize risk factors for development of NSF along with contributory cofactors that may increase risk. They will also understand steps to be taken that can mitigate risk in patients with compromised renal function.
- Understand what is meant by stability of a contrast agent, how it is measured and the various structural and chemical characteristics that affect stability.
- Gain an understanding of the current knowledge and outstanding issues related to Gd deposition in brain and other tissues in patients with normal renal function who receive GBCAs.
Target Audience
- Radiologic Technologists
- Radiology Administrators
Disclosures
Dr. Maravilla discloses honoraria, consulting and research support from Bracco, Guerbet and Philips Healthcare.
Dr. Tanenbaum discloses that he is a member of the speakers bureau for Guerbet, Bayer and GE.
Accreditation
Radiologic Technologists:
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for one (1) ARRT Category A CE Credit.
Radiology Administrators:
This course meets all CRA renewal credit criteria and has been approved for one (1) continuing education credit in the following CRA domains: Operations Management and Asset Management
Claiming CE Credit
To receive CME credits for participating in this CE activity you must successfully complete the online post examination. Online examinations return an immediate grade report. Upon receiving a passing grade of 70% or higher click continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate link displayed from within your MyCE Archives page.
Program Viewing Instructions
To begin program review click the View Program tab above. To start the video presentation position your cursor over the video player Icon and click.
System Hardware/Software and Internet Connection Requirements
The following information is provided for your reference in conjunction with review of this program.
Operating Systems: Windows 2000 or higher, MAC OSX 10.3 or higher, Mac iOS 5.0 or higher (ipad, iphone compatible), Android 4.3 or higher.
General System and Internet Requirements: Speakers or Headphones, High Speed Internet connection, Wireless 3G and 4G.
Web browsers: Internet Explorer, Firefox, Safari and Chrome.